Enter assignee name

Staidson (beijing) Biopharmaceuticals Co., Ltd.

Patents = 6

Trademarks = 4

Forward Citations = 0

where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents

12 inventors (with patents filed for the assignee):

Chao Wang (2 out of 73 patents)

Lei Ma (2 out of 50 patents)

Jianping Tan (2 out of 2 patents)

4. Bingzhang Wang (2 out of 2 patents)

5. Qingshuang Zhang (2 out of 2 patents)

6. Ming Liu (1 out of 133 patents)

7. Tianfei Du (1 out of 1 patent)

8. Maorong Yu (1 out of 2 patents)

9. Zhong Li (1 out of 1 patent)

10. Pingxia Zhu (1 out of 1 patent)

11. Qun Huang (1 out of 1 patent)

12. Ran Wu (1 out of 1 patent)

6 patents: Sort by Forward Citations

1. 12460008 - Antibodies specifically recognizing granulocyte-macrophage colony stimulating factor receptor alpha and uses thereof (2025-11-04),

2. 12448434 - Antibodies specifically recognizingPcrV and uses thereof (2025-10-21),

3. 11883464 - Nerve growth factor fusion protein, preparation method and use thereof (2024-01-30),

4. 11213568 - Nerve growth factor mutant (2022-01-04),

5. 11077193 - Nerve growth factor composition and powder injection (2021-08-03),

6. 10576129 - Nerve growth factor composition and powder injection (2020-03-03),

Staidson is a biopharmaceutical company based in Beijing, specializing in the research, development, and commercialization of innovative biotherapeutics for unmet medical needs. With a focus on oncology and rare diseases, Staidson is committed to improving the lives of patients through cutting-edge biotechnology and a strong pipeline of novel biologics.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

6 Patents

#357 in Beijing

#3,859 in China

Beijing, China